Trimax
TMXN · OTC
About TMXN
- Employees
- 0
- Headquarters
- FORT LAUDERDALE, Florida
- Listed
- Sep 25, 2001
- Sector
- Financials
- Industry
- Financial Services
- Website
- saavynaturals.com
TMXN key statistics
- Market cap
- 440.29K
- Price-earnings ratio
- 0.00
- Dividend yield
- —
- Average volume
- 411.78K
- Volume
- 58.70K
- Open price
- $0.0013
- High today
- $0.0017
- Low today
- $0.0013
- 52 Week high
- $0.0039
- 52 Week low
- $0.0006
Trimax (TMXN) at a glance
Trimax (TMXN) last traded at $0.0017, with a market cap of 440.29K and a price-to-earnings ratio of 0.00.
Today the stock has traded between $0.0013 and $0.0017. The current price is 30.8% above the day's low and 0.0% below its high.
Volume so far is 58.70K shares, below the average of 411.78K shares a day.
Over the past year Trimax has ranged from $0.0006 to $0.0039, and now sits 33% of the way up that range.
Similar companies
Companies in the same industry as Trimax
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- FRTTFort Technology$0.7121+32.63%
- SDSTStardust Power$0.02−23.66%
- CBDLCBD Life Sciences$0.0002−25.00%
- MDEXMadison Technologies$0.0005−37.50%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.